Logo image of CKX

CKX LANDS INC (CKX) Stock Fundamental Analysis

NYSEARCA:CKX - NYSE Arca - US12562N1046 - Common Stock - Currency: USD

11.62  +0.82 (+7.59%)

Fundamental Rating

5

Overall CKX gets a fundamental rating of 5 out of 10. We evaluated CKX against 64 industry peers in the Real Estate Management & Development industry. While CKX has a great health rating, its profitability is only average at the moment. CKX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CKX had positive earnings in the past year.
CKX had a positive operating cash flow in the past year.
CKX had positive earnings in 4 of the past 5 years.
Of the past 5 years CKX 4 years had a positive operating cash flow.
CKX Yearly Net Income VS EBIT VS OCF VS FCFCKX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M -2M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.05%, CKX belongs to the top of the industry, outperforming 90.77% of the companies in the same industry.
With a decent Return On Equity value of 4.10%, CKX is doing good in the industry, outperforming 73.85% of the companies in the same industry.
CKX's Return On Invested Capital of 1.94% is fine compared to the rest of the industry. CKX outperforms 63.08% of its industry peers.
Industry RankSector Rank
ROA 4.05%
ROE 4.1%
ROIC 1.94%
ROA(3y)-1.79%
ROA(5y)0.3%
ROE(3y)-1.81%
ROE(5y)0.33%
ROIC(3y)N/A
ROIC(5y)N/A
CKX Yearly ROA, ROE, ROICCKX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

CKX's Profit Margin of 44.41% is amongst the best of the industry. CKX outperforms 100.00% of its industry peers.
CKX's Profit Margin has declined in the last couple of years.
CKX has a better Operating Margin (33.58%) than 95.38% of its industry peers.
In the last couple of years the Operating Margin of CKX has declined.
CKX has a Gross Margin of 95.63%. This is amongst the best in the industry. CKX outperforms 96.92% of its industry peers.
CKX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 33.58%
PM (TTM) 44.41%
GM 95.63%
OM growth 3Y-25.78%
OM growth 5Y-31.46%
PM growth 3Y-46.93%
PM growth 5Y-11.79%
GM growth 3Y1.02%
GM growth 5Y1.2%
CKX Yearly Profit, Operating, Gross MarginsCKX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

8

2. Health

2.1 Basic Checks

CKX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CKX has more shares outstanding
The number of shares outstanding for CKX has been increased compared to 5 years ago.
There is no outstanding debt for CKX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CKX Yearly Shares OutstandingCKX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
CKX Yearly Total Debt VS Total AssetsCKX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 56.97 indicates that CKX is not in any danger for bankruptcy at the moment.
CKX's Altman-Z score of 56.97 is amongst the best of the industry. CKX outperforms 100.00% of its industry peers.
There is no outstanding debt for CKX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 56.97
ROIC/WACC0.21
WACC9.07%
CKX Yearly LT Debt VS Equity VS FCFCKX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 37.53 indicates that CKX has no problem at all paying its short term obligations.
CKX has a Current ratio of 37.53. This is amongst the best in the industry. CKX outperforms 100.00% of its industry peers.
A Quick Ratio of 37.53 indicates that CKX has no problem at all paying its short term obligations.
CKX has a Quick ratio of 37.53. This is amongst the best in the industry. CKX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 37.53
Quick Ratio 37.53
CKX Yearly Current Assets VS Current LiabilitesCKX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

3

3. Growth

3.1 Past

CKX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1491.04%, which is quite impressive.
Measured over the past years, CKX shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.10% on average per year.
CKX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 18.18%.
CKX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.40% yearly.
EPS 1Y (TTM)1491.04%
EPS 3Y-33.9%
EPS 5Y-1.1%
EPS Q2Q%130%
Revenue 1Y (TTM)18.18%
Revenue growth 3Y26.89%
Revenue growth 5Y13.4%
Sales Q2Q%150%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CKX Yearly Revenue VS EstimatesCKX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 31.41, the valuation of CKX can be described as expensive.
75.38% of the companies in the same industry are more expensive than CKX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CKX to the average of the S&P500 Index (27.41), we can say CKX is valued inline with the index average.
Industry RankSector Rank
PE 31.41
Fwd PE N/A
CKX Price Earnings VS Forward Price EarningsCKX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CKX is valued a bit cheaper than 78.46% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CKX is valued a bit cheaper than the industry average as 70.77% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 36.02
EV/EBITDA 14.78
CKX Per share dataCKX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The decent profitability rating of CKX may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CKX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CKX LANDS INC

NYSEARCA:CKX (7/10/2025, 8:04:02 PM)

11.62

+0.82 (+7.59%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)05-12 2025-05-12
Earnings (Next)08-11 2025-08-11
Inst Owners6.48%
Inst Owner Change0%
Ins Owners4.46%
Ins Owner Change0%
Market Cap23.82M
Analysts0
Price TargetN/A
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 31.41
Fwd PE N/A
P/S 13.79
P/FCF 36.02
P/OCF 36.02
P/B 1.27
P/tB 1.27
EV/EBITDA 14.78
EPS(TTM)0.37
EY3.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.32
FCFY2.78%
OCF(TTM)0.32
OCFY2.78%
SpS0.84
BVpS9.12
TBVpS9.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.05%
ROE 4.1%
ROCE 3.1%
ROIC 1.94%
ROICexc 3.91%
ROICexgc 3.91%
OM 33.58%
PM (TTM) 44.41%
GM 95.63%
FCFM 38.28%
ROA(3y)-1.79%
ROA(5y)0.3%
ROE(3y)-1.81%
ROE(5y)0.33%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-7.11%
ROICexcg growth 5Y-22.44%
ROICexc growth 3Y-7.11%
ROICexc growth 5Y-22.44%
OM growth 3Y-25.78%
OM growth 5Y-31.46%
PM growth 3Y-46.93%
PM growth 5Y-11.79%
GM growth 3Y1.02%
GM growth 5Y1.2%
F-Score6
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 113.18%
Profit Quality 86.2%
Current Ratio 37.53
Quick Ratio 37.53
Altman-Z 56.97
F-Score6
WACC9.07%
ROIC/WACC0.21
Cap/Depr(3y)303.54%
Cap/Depr(5y)413.1%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1491.04%
EPS 3Y-33.9%
EPS 5Y-1.1%
EPS Q2Q%130%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)18.18%
Revenue growth 3Y26.89%
Revenue growth 5Y13.4%
Sales Q2Q%150%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1971.79%
EBIT growth 3Y-5.83%
EBIT growth 5Y-22.28%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100.88%
FCF growth 3YN/A
FCF growth 5Y4.05%
OCF growth 1Y78.06%
OCF growth 3YN/A
OCF growth 5Y1.02%